Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649
Diabetes Mellitus, Diabetes Mellitus, Type 2
Baton Rouge, Louisiana, United States
View Trial DetailsNCT Number: NCT01339637
The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Radiant Research, Birmingham, Alabama, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
OR
Exclusion criteria
Time frame: 6 months
The primary study endpoint is the relative true positive and relative true negative fractions between the SCOUT DS and FPG test for detecting abnormal glucose tolerance (2 hr OGTT value ≥ 140 mg/dL).
Time frame: 6 months
Secondary endpoint is to evaluate the receiver operator characteristic area under the curve, sensitivity, specificity, and positive (PPV) and negative (NPV) predictive values of SCOUT DS, FPG, and A1C test for detection of abnormal glucose tolerance.
VeraLight, Inc.
Industry
Acronym: LSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01234649
Diabetes Mellitus, Diabetes Mellitus, Type 2
Baton Rouge, Louisiana, United States
View Trial DetailsNCT04529473
Glucose Intolerance, Glucose Metabolism Disorders
Chicago, Illinois, United States
View Trial DetailsNCT01414647
Dyslipidemia, Dyslipidemias
Kuopio, Finland
View Trial DetailsNCT00536250
Body Weight, Childhood Obesity
New Haven, Connecticut, United States
View Trial Details